(USD) | Mar 2022 | Q/Q |
---|---|---|
Revenue | 565.4MM | +2% |
Gross Profit | 378.3MM | - |
Cost Of Revenue | 187MM | - |
Operating Income | - | - |
Operating Expenses | - | - |
Net Income | - | - |
R&D | - | - |
G&A | - | - |
Amortization | - | - |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Teladoc's (TDOC) Integrated Care business is expected to gain from margin expansion and improving chronic care program enrollment.
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Teladoc Health Inc (NYSE:TDOC), a multinational telemedicine and virtual healthcare company, has seen a recent insider transaction according to the latest SEC filings.
The latest trading day saw Teladoc (TDOC) settling at $15.08, representing a +0.53% change from its previous close.
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Teladoc Health (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Teladoc (TDOC) reachead $15.12 at the closing of the latest trading day, reflecting no change compared to its last close.
Teladoc (TDOC) closed the most recent trading day at $15.37, moving -1.41% from the previous trading session.
Teladoc Health (TDOC) expands weight management capabilities by coming up with a tailored solution that aims to reduce obesity-related medical care expenses for members.
The bleeding continues for this telehealth leader.